AWA
RPRX icon

Aaron Wealth Advisors’s Royalty Pharma RPRX Stock Holding History

Aaron Wealth Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
7,888
-1,366
-15% -$71.1K 0.02% 454
2026
Q1 		$444K Sell
9,254
-1,046
-10% -$45.8K 0.03% 420
2025
Q4 		$398K Sell
10,300
-2,060
-17% -$78.6K 0.02% 500
2025
Q3 		$436K Buy
+12,360
New +$447K 0.03% 443

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aaron Wealth Advisors's RPRX Position: Q2 2026 in Review

Aaron Wealth Advisors reduced its Royalty Pharma (RPRX) stake by 15% in Q2 2026, selling an estimated $71.1K and leaving 7,888 shares worth $442K. The position accounts for 0.02% of the portfolio, ranked #454.

Aaron Wealth Advisors first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $444K in Q1 2026. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Aaron Wealth Advisors held 7,888 shares of Royalty Pharma worth $442K as of Q2 2026.
  • Aaron Wealth Advisors sold 1,366 Royalty Pharma shares in Q2 2026, an estimated $71.1K.
  • Royalty Pharma made up 0.02% of Aaron Wealth Advisors's portfolio in Q2 2026, its #454 holding.
  • Aaron Wealth Advisors first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • Aaron Wealth Advisors's Royalty Pharma position peaked at $444K in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.